Can a Framework Be Established for the Safe Use of Ketamine?

The article presents a research study on clinical use of intranasal ketamine for treatment-resistant or acutely suicidal patients with depression. Topics discussed include the therapeutic effect of overusing ketamines for mood elevation; the guidelines made for marketing and distribution of ketamine by the Food & Drug Administration (FDA) in U.S.; and education of the public and physicians about the risk of drug abuse.